[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
Next Issue
Volume 32, March
Previous Issue
Volume 31, September
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 

Pathophysiology, Volume 31, Issue 4 (December 2024) – 15 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Section
Select all
Export citation of selected articles as:
10 pages, 1015 KiB  
Article
Low Renalase Levels in Newly Diagnosed CML: Dysregulation Sensitive to Modulation by Tyrosine Kinase Inhibitors
by Jelena Milenkovic, Dijana Stojanovic, Sanja Velickovic, Branka Djordjevic, Goran Marjanovic and Maja Milojkovic
Pathophysiology 2024, 31(4), 787-796; https://doi.org/10.3390/pathophysiology31040053 - 10 Dec 2024
Viewed by 665
Abstract
Background: A dysregulated proinflammatory microenvironment is considered one of the reasons why current therapies of chronic myeloid leukemia (CML) with tyrosine kinase inhibitors (TKI) do not secure disease control. Therefore, the development of BCR-ABL1-independent therapies is encouraged. Renalase (RNLS) is a multifunctional protein [...] Read more.
Background: A dysregulated proinflammatory microenvironment is considered one of the reasons why current therapies of chronic myeloid leukemia (CML) with tyrosine kinase inhibitors (TKI) do not secure disease control. Therefore, the development of BCR-ABL1-independent therapies is encouraged. Renalase (RNLS) is a multifunctional protein that exhibits both enzymatic and non-enzymatic cytokine-like properties, along with potent anti-inflammatory and anti-apoptotic effects. It is expressed in various tissues, including tumors. Methods: We investigated the levels of RNLS in the blood of CML patients in the chronic phase, treatment naïve patients, and those in remission under TKI treatment (either imatinib or nilotinib) and compared them to healthy individuals. Results: Renalase concentration was markedly decreased in treatment-naive CML patients compared to other groups (p = 0.000), while lower levels in the TKI group were not statistically significant compared to controls. The levels correlated negatively with the total leukocyte and neutrophil count (p < 0.05), while a positive correlation was present with CRP levels in treatment naïve patients. Conclusions: Dynamic regulation of RNLS expression and activity is coupled with transcription factors NF-κB and STAT3. Interpretation of our results might rely on differential requirements of activated STATs (STAT3/5) during CML clone development and maintenance, including the observation of RNLS rise upon TKI introduction. Overall, our research provides new insights into the field of hematological malignancies. Unlike other malignancies studied, RNLS plasma levels are significantly decreased in CML. In future perspectives, RNLS could potentially serve as a diagnostic, prognostic, or therapeutic option for these patients. Full article
Show Figures

Figure 1

Figure 1
<p>Comparison of the RNLS concentration between the groups. * <span class="html-italic">p</span> = 0.000 compared to the CML treatment-naïve group.</p>
Full article ">Figure 2
<p>Correlation between the RNLS concentration and leukocyte count. (<b>a</b>) The correlation of RNLS to white blood cell (WBC) count; (<b>b</b>) The correlation of RNLS to neutrophil granulocyte count.</p>
Full article ">
26 pages, 2700 KiB  
Review
Chronic Kidney Disease of Unknown Etiology: A Global Health Threat in Rural Agricultural Communities—Prevalence, Suspected Causes, Mechanisms, and Prevention Strategies
by Zineb Ben Khadda, Haitam Lahmamsi, Yahya El Karmoudi, Said Ezrari, Laila El Hanafi and Tarik Sqalli Houssaini
Pathophysiology 2024, 31(4), 761-786; https://doi.org/10.3390/pathophysiology31040052 - 9 Dec 2024
Viewed by 1486
Abstract
Chronic Kidney Disease of Unknown Etiology (CKDu) is a worldwide hidden health threat that is associated with progressive loss of kidney functions without showing any initial symptoms until reaching end-stage renal failure, eventually leading to death. It is a growing health problem in [...] Read more.
Chronic Kidney Disease of Unknown Etiology (CKDu) is a worldwide hidden health threat that is associated with progressive loss of kidney functions without showing any initial symptoms until reaching end-stage renal failure, eventually leading to death. It is a growing health problem in Asia, Central America, Africa, and the Middle East, with identified hotspots. CKDu disease mainly affects young men in rural farming communities, while its etiology is not related to hypertension, kidney stones, diabetes, or other known causes. The main suspected causal factors are heat-stress, dehydration, exposure to agrochemicals, heavy metals and use of hard water, infections, mycotoxins, nephrotoxic agents, altitude, and genetic factors. This review gives an overview of CKDu and sheds light on its medical history, geographic distribution, and worldwide prevalence. It also summarizes the suspected causal factors, their proposed mechanisms of action, as well as the main methods used in the CKDu prior detection and surveillance. In addition, mitigation measures to reduce the burden of CKDu are also discussed. Further investigation utilizing more robust study designs would provide a better understanding of the risk factors linked to CKDu and their comparison between affected regions. Full article
Show Figures

Figure 1

Figure 1
<p>Geographical distribution of CKDu. in the Mesoamerican region [<a href="#B11-pathophysiology-31-00052" class="html-bibr">11</a>,<a href="#B12-pathophysiology-31-00052" class="html-bibr">12</a>], in Srilanka [<a href="#B13-pathophysiology-31-00052" class="html-bibr">13</a>], in Morocco [<a href="#B14-pathophysiology-31-00052" class="html-bibr">14</a>], in Tunisia [<a href="#B15-pathophysiology-31-00052" class="html-bibr">15</a>], in Egypt [<a href="#B16-pathophysiology-31-00052" class="html-bibr">16</a>], in India [<a href="#B17-pathophysiology-31-00052" class="html-bibr">17</a>], and in Mexico [<a href="#B7-pathophysiology-31-00052" class="html-bibr">7</a>].</p>
Full article ">Figure 2
<p>Heat stress-induced renal injury. Heat stress-mediated hyperosmolarity activates vasopressin; released vasopressin increases vasoconstriction. The activation of the polyol pathway converts glucose to fructose and increases ROS levels, activating the inflammatory pathway. ER and mitochondrial stress also activate the cell death pathway. This figure was exported under a paid subscription with BioRender.</p>
Full article ">Figure 3
<p>Common pathways of toxins induced renal injury. Alteration in the mitochondrial electron transport chain and main oxidases such as NADPH oxidase led to excessive ROS production with toxins exposure. Increased ROS generation activates and induces some pathways, such as the caspase pathway, inhibition of lysosome enzymatic function, lipid peroxidation, cell death, and inflammation. This figure was exported under a paid subscription with BioRender.</p>
Full article ">Figure 4
<p>Kidney injury biomarkers.</p>
Full article ">
52 pages, 6090 KiB  
Review
Rat Models in Post-Traumatic Stress Disorder Research: Strengths, Limitations, and Implications for Translational Studies
by Alexey Sarapultsev, Maria Komelkova, Oleg Lookin, Sergey Khatsko, Evgenii Gusev, Alexander Trofimov, Tursonjan Tokay and Desheng Hu
Pathophysiology 2024, 31(4), 709-760; https://doi.org/10.3390/pathophysiology31040051 - 6 Dec 2024
Viewed by 849
Abstract
Post-Traumatic Stress Disorder (PTSD) is a multifaceted psychiatric disorder triggered by traumatic events, leading to prolonged psychological distress and varied symptoms. Rat models have been extensively used to explore the biological, behavioral, and neurochemical underpinnings of PTSD. This review critically examines the strengths [...] Read more.
Post-Traumatic Stress Disorder (PTSD) is a multifaceted psychiatric disorder triggered by traumatic events, leading to prolonged psychological distress and varied symptoms. Rat models have been extensively used to explore the biological, behavioral, and neurochemical underpinnings of PTSD. This review critically examines the strengths and limitations of commonly used rat models, such as single prolonged stress (SPS), stress–re-stress (S-R), and predator-based paradigms, in replicating human PTSD pathology. While these models provide valuable insights into neuroendocrine responses, genetic predispositions, and potential therapeutic targets, they face challenges in capturing the full complexity of PTSD, particularly in terms of ethological relevance and translational validity. We assess the degree to which these models mimic the neurobiological and behavioral aspects of human PTSD, highlighting areas where they succeed and where they fall short. This review also discusses future directions in refining these models to improve their utility for translational research, aiming to bridge the gap between preclinical findings and clinical applications. Full article
Show Figures

Figure 1

Figure 1
<p>Schematic picture of two classical designs for the electric shock models—Footshock (<b>A</b>) and Inescapable Tail Shock models (<b>B</b>). The animal is kept inside the chamber to restrict movement during shocks. The electrical impulses are supplied either on the floor to affect the feet (<b>A</b>) or to the panel to which the tail can touch.</p>
Full article ">Figure 2
<p>Schematic picture of different approaches used to restrict the movement of an animal. (<b>A</b>) Each foot of the animal is fixed to prevent movement while the body is not fixed (the animal can move its head and tail). (<b>B</b>) The animal is placed in a transparent chamber restricting its lateral movement to the desired extent (adjusted by the restriction block). (<b>C</b>) The animal is fully enclosed by a transparent bag restricting its movement while not preventing its breathing. Note that all approaches do not block seeing or hearing, thus simulating stress in humans.</p>
Full article ">Figure 3
<p>A simplified representation of the underwater trauma (UWT) model used to stress an animal. The animal is allowed to swim in an open pool without an underwater platform for a short period (typically 30 s). The pool is closed by a metal net to submerge the animal underwater and induce sudden stress because the animal cannot emerge from the water during this time.</p>
Full article ">Figure 4
<p>A simplified representation of predator-based models. (<b>A</b>) The animal is exposed to a predator scent or odor (urea, fur, or collar) but is not exposed to direct contact with the predator. This method provides the highest level of protection for the animal. (<b>B</b>) The animal is exposed to the direct view of the predator (and often in the common space allowing transmission of scents and dangerous sounds), but direct contact between the animal and the predator is blocked, thus providing an intermediate danger level. (<b>C</b>) The animal is exposed to direct contact with the predator. In this method, the only barrier between the animal and the predator is a transparent shield, which partially blocks the contact but does not prevent attack. The methods simulate the most dangerous situations.</p>
Full article ">Figure 5
<p>A progression plot for the proposed “ideal” design and strategy for experimental research using PTSD animal models (rats in this case).</p>
Full article ">
10 pages, 1549 KiB  
Article
Placental Macrovascular Pattern from Pregnancies with Maternal Hypertensive and Fetal Growth Capacity Complications
by Kamilya Makhambetova, Yevgeniy Kamyshanskiy, Olga Ponamareva, Zhanna Amirbekova, Nazerke Oshakhtiyeva and Saule Kunanbaeva
Pathophysiology 2024, 31(4), 699-708; https://doi.org/10.3390/pathophysiology31040050 - 5 Dec 2024
Viewed by 402
Abstract
Histomorphometric measurements of the wall thickness and internal diameter of the macrovessels of the chorionic villi of placentas from pregnancies complicated by preeclampsia or fetal growth restriction in comparison with normotensive pregnancy. Methods: The research included placentas from singleton pregnancies complicated by preeclampsia [...] Read more.
Histomorphometric measurements of the wall thickness and internal diameter of the macrovessels of the chorionic villi of placentas from pregnancies complicated by preeclampsia or fetal growth restriction in comparison with normotensive pregnancy. Methods: The research included placentas from singleton pregnancies complicated by preeclampsia and/or fetal growth restriction, women delivered in medical institutions in Karaganda city (Kazakhstan). Placentas were divided into three groups: PE (n = 59), isolated FGR (n = 24), and PE with FGR (n = 41). The control group consisted of normotensive pregnancies, compared by gestation period. Placental examination and selection of placental tissue fragments were carried out in accordance with the consensus recommendations of the Amsterdam Placental Workshop Group. The sections were stained with hematoxylin and eosin and Masson trichrome. Morphometric measurements were performed using ImageJ software version 1.52p. Results: Our data showed that, in the PE group, there was a significant decrease in the wall thickness of the proximal and distal vessels with an increase in internal diameter compared with the control group (p < 0.01). In the PE + FGR group, there was a thickening of the wall of the proximal part of the vessels with a decrease in their lumen and a decrease in the wall thickness of the vessels with an increase in the lumen in the distal part compared with the control group (p < 0.01). Conclusions: Two histopatterns of placental macrovessels in preeclampsia were revealed: the histophenotype of diffuse (proximal and distal) ectatic macroangiopathy with a thin vascular wall with a decrease in the thickness of the muscle layer and the histophenotype of proximal fibromuscular sclerosis with vascular obliteration/spasm and distal ectatic macroangiopathy. We believe that significant structural differences in vascular remodeling may reflect the different temporal and spatial nature of the pathological factor. Future research is needed to investigate the associations between histopatterns of placental vascular remodeling in preeclampsia and long-term perinatal/maternal outcomes. Full article
Show Figures

Figure 1

Figure 1
<p>Wall thickness of proximal and distal macrovessels of placentas of the control group (normotensive pregnancy) and groups with preeclampsia and complications associated with impaired fetal growth, microns. Diagram illustrating the distribution of placental macrovascular wall thickness (μm) in the study groups (circles (<span class="html-fig-inline" id="pathophysiology-31-00050-i001"><img alt="Pathophysiology 31 00050 i001" src="/pathophysiology/pathophysiology-31-00050/article_deploy/html/images/pathophysiology-31-00050-i001.png"/></span>) minor emissions, defined as values in the range from 1.5 to 3 interquartile ranges (IQR); stars (<span class="html-fig-inline" id="pathophysiology-31-00050-i002"><img alt="Pathophysiology 31 00050 i002" src="/pathophysiology/pathophysiology-31-00050/article_deploy/html/images/pathophysiology-31-00050-i002.png"/></span>)—extreme emissions, defined as values greater than 3 interquartile ranges (IQR).); Assessment of placental macrovascular wall thickness in the preeclampsia and fetal growth restriction groups compared with the control group.</p>
Full article ">Figure 2
<p>Histomorphological picture of vascular remodeling in the placentas of the researched groups. Masson trichrome, magnification: ×100. (<b>a</b>) PE, 36 weeks, ectasia of the vessel lumen with thinning of the muscle wall (collagen fibers are shown in blue, muscle tissue in red (arrows)); (<b>b</b>) PE + FGR, 36 weeks, thickening of the vessel walls with a decrease in the diameter of the vessel lumen.</p>
Full article ">
19 pages, 4172 KiB  
Article
Exploration of the Topical Nanoemulgel Bearing with Ferulic Acid and Essential Oil for Diabetic Wound Healing
by Urati Anuradha, Valamla Bhavana, Padakanti Sandeep Chary, Nitin Pal Kalia and Neelesh Kumar Mehra
Pathophysiology 2024, 31(4), 680-698; https://doi.org/10.3390/pathophysiology31040049 - 25 Nov 2024
Viewed by 742
Abstract
Aim: To investigate the anti-inflammatory, antioxidant, and diabetic wound healing properties of the novel topical formulation [Ferulic acid-loaded nanoemulgel (DLMGO-G)]. Methods: Ferulic acid nanoemulsion developed with lemongrass oil is investigated in diabetic wound healing. Further nanoemulsion is incorporated into 1% carbopol® 934 [...] Read more.
Aim: To investigate the anti-inflammatory, antioxidant, and diabetic wound healing properties of the novel topical formulation [Ferulic acid-loaded nanoemulgel (DLMGO-G)]. Methods: Ferulic acid nanoemulsion developed with lemongrass oil is investigated in diabetic wound healing. Further nanoemulsion is incorporated into 1% carbopol® 934 to obtain the DLMGO-G. Nanoemulsion was characterized for particle size, and polydispersity index (PDI) was obtained by Malvern Zetasizer (Zetasizer Nano ZS, Malvern, AL, USA), and morphology by TEM (JEM 1400, JOEL, Akishima, Japan). Furthermore, in vitro cell line and in vivo studies were carried out. Results: The developed nanoemulsion showed a globule size of 28.04 ± 0.23 nm and PDI of 0.07 ± 0.01. The morphology of nanoformulations by TEM confirmed the spherical and uniform nature. Further, the nanoformulation in in vitro cell line experiments revealed that the IC50 value was increased by 1.52 times compared to the drug solution. The treatment groups have shown that fibroblast morphologies were spindle-shaped, suggesting that nanoformulation was compatible with the cells and developed normally on nanoformulation. It also reduced ROS with improved internalization more than the control group. The in vitro wound healing model also revealed that nanoformulation had better wound healing activity. In the in vivo diabetic wound studies on male SD rats, the levels of inflammatory markers such as TNF-α, IL-6, IL-22, and IL-1β declined significantly when treated with DLMGO-G. IL-10 levels significantly increased compared to the diseased group, and MMP-9 levels were remarkably decreased compared to the diseased group. Furthermore, histopathological studies showed the regeneration and granulation of tissues. Conclusions: Thus, these findings indicate that FA-loaded nanoemulgel greatly accelerates the healing of wounds in diabetic rats. Full article
Show Figures

Figure 1

Figure 1
<p>The schematic representation of the in vivo study design to assess the formulation on STZ-induced SD rats.</p>
Full article ">Figure 2
<p>Characterization of drug-loaded nanoemulsion (DLMGONE) and drug-loaded nanoemulgel (DLMGO-G); (<b>A</b>) Droplet-size distribution analysis of DLMGONE. (<b>B</b>,<b>C</b>) Transmission electron microscopy (TEM) image of DLMGONE and DLMGO-G with scale 100 nm and 200 nm, respectively.</p>
Full article ">Figure 3
<p>(<b>A</b>) Cytotoxicity study by MTT assay of nanoformulation. Cellular uptake study (<b>B1</b>–<b>B4</b>): (<b>B1</b>) Control group; (<b>B2</b>) An amount of 10 UL of dye solution; (<b>B3</b>) IC50 of dye-loaded nanoformulation; and (<b>B4</b>) High dose of dye-loaded nanoformulation. DCFDA staining (<b>C1</b>–<b>C4</b>): (<b>C1</b>) Control group; (<b>C2</b>) LPS-treated group; (<b>C3</b>) IC50 of nanoformulation; and (<b>C4</b>) High dose of nanoformulation.</p>
Full article ">Figure 4
<p>Acridine orange and ethidium bromide (AO/EB) dual staining of nanoformulation.</p>
Full article ">Figure 5
<p>(<b>A</b>–<b>C</b>): (<b>A</b>) In vitro scratch assay of nanoformulation (IC50 and high dose) for wound closure on L929 cell lines. (<b>B</b>) % wound closure was quantified using ImageJ software, version 1.45. * <span class="html-italic">p</span> &lt; 0.05 vs. Control. (<b>C</b>) Morphological assay of nanoformulation.</p>
Full article ">Figure 6
<p>(<b>A</b>–<b>C</b>): (A) Dorsal view phenotypic photos exhibiting the subjects; (<b>B</b>) The % of wound closure of each group on different days; (<b>C</b>) The wound area of each group on different days.</p>
Full article ">Figure 7
<p>(<b>A1</b>–<b>C6</b>): (<b>A1</b>) Glucose levels by glucometer of different groups on different days; (<b>A2</b>) Bodyweight of each group on different days; (<b>A3</b>) God-pod assay of different groups; (<b>B1</b>,<b>B2</b>) Effect of Nitrite and TBARS levels on STZ intoxication and Novel nanoformulation treatment; (<b>C1</b>–<b>C5</b>) Effect of inflammatory and anti-inflammatory cytokines such as TNF-α, IL-1β, IL-22, IL-6, and IL-10 on STZ intoxication and Novel nanoformulation treatment; (<b>C6</b>) MMP-9 levels of different groups. All values were analyzed by one-way ANOVA followed by Tukey’s multiple comparison test and expressed as mean ± S.E.M and <sup>####</sup> <span class="html-italic">p</span> &lt; 0.0001 vs. Control (C), <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 vs. C, <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 vs. C, <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 vs. C, **** <span class="html-italic">p</span> &lt; 0.0001 vs. disease (D), *** <span class="html-italic">p</span> &lt; 0.001 vs. D, ** <span class="html-italic">p</span> &lt; 0.01 vs. D, * <span class="html-italic">p</span> &lt; 0.05 vs. D.</p>
Full article ">Figure 8
<p>Rat skin stained with hematoxylin and eosin for histopathological analysis (<b>A1</b>–<b>A5</b>): (<b>A1</b>) Healthy group; (<b>A2</b>) Disease group; (<b>A3</b>) Marketed group; (<b>A4</b>) Blank nanoemulgel (BLMGO-G); and (<b>A5</b>) Drug loaded nanoemulgel (DLMGO-G). PSR Red staining of rat skin (<b>B1</b>–<b>B5</b>): (<b>B1</b>) Healthy group; (<b>B2</b>) Disease group; (<b>B3</b>) Marketed group; (<b>B4</b>) BLMGO-G; and (<b>B5</b>) DLMGO-G. PSR staining of rat skin in polarized light images (<b>C1</b>–<b>C5</b>): (<b>C1</b>) Healthy group; (<b>C2</b>) Disease group; (<b>C3</b>) Marketed group; (<b>C4</b>) BLMGO-G; and (<b>C5</b>) DLMGO-G. Each of the histopathology studies has a scale of 100 µm.</p>
Full article ">
19 pages, 587 KiB  
Systematic Review
Interplay Between Vitamin D Levels and Heavy Metals Exposure in Pregnancy and Childbirth: A Systematic Review
by Tania Flores-Bazán, Jeannett Alejandra Izquierdo-Vega, José Antonio Guerrero-Solano, Araceli Castañeda-Ovando, Diego Estrada-Luna and Angélica Saraí Jiménez-Osorio
Pathophysiology 2024, 31(4), 660-679; https://doi.org/10.3390/pathophysiology31040048 - 21 Nov 2024
Viewed by 818
Abstract
Background/Objectives: Vitamin D (VD) deficiency has been associated with increased risk of gestational disorders affecting the endocrine system, immune system, and neurodevelopment in offspring. Recent studies have focused on the interaction between toxic elements and micronutrients during pregnancy. This review analyzes the potential [...] Read more.
Background/Objectives: Vitamin D (VD) deficiency has been associated with increased risk of gestational disorders affecting the endocrine system, immune system, and neurodevelopment in offspring. Recent studies have focused on the interaction between toxic elements and micronutrients during pregnancy. This review analyzes the potential relationships between VD levels and heavy metals in pregnant women and their offspring. Methods: A systematic review was conducted according to PRISMA 2020 guidelines, using databases such as PubMed, ScienceDirect, Cochrane Library, and Google Scholar. Boolean operators ‘AND’ and ‘OR’ were applied with terms like ‘pregnancy’, ‘vitamin D’, ‘heavy metals’, and ‘newborns’. Results: From 4688 articles, 14 studies were selected based on relevance and quality. These studies measured the levels of metals like lead (Pb), cadmium (Cd), mercury (Hg), and arsenic (As), in biological samples including maternal blood, umbilical cord blood, placenta tissue, and meconium during different stages of pregnancy, showing an inverse relationship between VD deficiency and heavy metal concentrations, which could be related to the incidence of preterm birth. Conclusions: The review highlights the importance of maintaining adequate VD levels during pregnancy, suggesting that sufficient VD may mitigate the adverse effects of heavy metal exposure, potentially reducing pregnancy-related complications. Full article
Show Figures

Figure 1

Figure 1
<p>PRISMA flow diagram of the systematic review.</p>
Full article ">
17 pages, 3196 KiB  
Article
Comparative Study of Injected Alzheimer’s Disease Models in Rats: Insights from Experimental Research
by Hanane Doumar, Hicham El Mostafi, Aboubaker Elhessni, Abderrahim Laaziz and Abdelhalem Mesfioui
Pathophysiology 2024, 31(4), 643-659; https://doi.org/10.3390/pathophysiology31040047 - 20 Nov 2024
Viewed by 743
Abstract
Background/Objectives: Alzheimer’s disease (AD) remains incurable, highlighting the need for new and diverse animal models to better understand its complex mechanisms. This study compares various injected animal models of AD, focusing on the main theories that explain the disease; Methods: Female Wistar rats [...] Read more.
Background/Objectives: Alzheimer’s disease (AD) remains incurable, highlighting the need for new and diverse animal models to better understand its complex mechanisms. This study compares various injected animal models of AD, focusing on the main theories that explain the disease; Methods: Female Wistar rats (10-months old) were administered intracebroventricularly by artificial cerebrospinal fluid (aCSF) (Control), beta amyloid Aβ1-42 (BA), okadaic acid (OKA), lipopolysaccharides (LPS), buthionine sulfoximine (BSO) or by a mixture of these different molecules (MLG). Cognitive performance was assessed one week or one month after stereotaxic surgery; Results: Our results, show that only the Aβ and the MLG induced a persistence and progressive deficits in the working memory, recognition memory and spatial memory in rats. As the hippocampus (HIP) and the prefrontal cortex (PFC) are particularly involved in memory behavior, we analyzed long-term neuroadaptations in these brain subregions using spectrophotometric and histological methods to assess oxidative stress changes and neuronal loss, respectively. We found that the behavioral impairments in memory and learning were accompanied by irreversible oxidative stress changes and neurodegenerescence, particularly in the HIP; Conclusions: This study provides promising data on the modeling of AD in order to develop an effective therapeutic approach. Full article
Show Figures

Figure 1

Figure 1
<p>Experimental timeline.</p>
Full article ">Figure 2
<p>Cognitive performance in the Y-Maze (Y-Mz), Novel Object Recognition (NOR) and Morris water maze (MWM) tests. These tests were performed 1 week (1W) or 1 month (1M) after the stereotaxic surgery in rats injected by aCSF (CTR), beta amyloid Aβ1-42 (BA), okadaic acid (OKA), lipopolysaccharides (LPS), buthionine sulfoximine (BSO) or by a mixture of these different molecules (MLG). Bars represent the mean ± SEM. of (<b>A</b>) the Y-maze spontaneous alternation (%), (<b>B</b>) the recognition index (%), (<b>C</b>,<b>D</b>) the latency to reach the hidden platform (s) in the MWM, one week and one month after stereotaxic surgery, respectively, (<b>E</b>) the time in the quadrant cible assessed during a probe trial of the MWM, (<b>F</b>) The Cognition <math display="inline"><semantics> <mrow> <mi>Z</mi> </mrow> </semantics></math>-score was calculated based on the animals’ performances in the three preceding behavioral tests. Symbols Signification: * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001 vs. CTR; <sup>k</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>kk</sup> <span class="html-italic">p</span> &lt; 0.01 vs. AOK; <sup>p</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>pp</sup> <span class="html-italic">p</span> &lt; 0.01 vs. LPS; <sup>b</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>bbb</sup> <span class="html-italic">p</span> &lt; 0.001 vs. BTN according to two-way ANOVA followed by Tukey’s test.</p>
Full article ">Figure 3
<p>Histologic quantification of neurons in rats’ brain. (<b>A</b>) Regions of interest and their anatomical positions: prelimbic cortex (PrL), medial coretx (M1), hippocampal pyramidal cell (CA3) and dental gyrus (DG) (2.70 and −3.80 mm relative to bregma; left hemisphere). (<b>B</b>) Number of neurons per mm2 assessed by cell counting in PrL, M1, CA3 and DG subregions. (<b>C</b>) Representative Nissl-stained forebrain sections showing potential inflammatory infiltration in the MLG group (green arrows) across the M1, PrL, CA1 and CA3 brain subregions. The data are illustrated as box-and-whisker plots for CTR, OKA, LPS, BSO, BA and MLG groups. Each value represents the mean ± SEM. from 5 animals per group. Symbols Signification: * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 vs. CTR according to Kruskal–Wallis ANOVA, and Dunn’s multiple comparison test. Scale bars: 200 µm. Drawings are adapted from Paxinos &amp; Watson, (2013). All coordinates for the studied subregions were obtained from the rat brain atlas [<a href="#B23-pathophysiology-31-00047" class="html-bibr">23</a>].</p>
Full article ">Figure 4
<p>Histologic semi-quantitative analysis of neurodegeneration in rats’ brain. (<b>A</b>) Score of Neurodegeneration in prelimbic cortex (PrL), medial coretx (M1), hippocampal pyramidal cell (CA3) and dental gyrus (DG) subregions. (<b>B</b>) Representative images of Nissl-stained forebrain sections (2.70 and −3.80 mm relative to bregma; left hemisphere; PrL, M1, CA3, and DG) for CTR, OKA, LPS, BSO, BA, and MLG groups. Cellular loss and areas of neurodegeneration are indicated by black and red arrows, respectively. Each value represents the mean ± SEM. from 5 animals per group. Symbols Signification: * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001 vs. CTR; <sup>k</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>kk</sup> <span class="html-italic">p</span> &lt; 0.01, <sup>kkk</sup> <span class="html-italic">p</span> &lt; 0.001 vs. AOK; <sup>p</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>pp</sup> <span class="html-italic">p</span> &lt; 0.01, <sup>ppp</sup> <span class="html-italic">p</span> &lt; 0.001 vs. LPS; <sup>bb</sup> <span class="html-italic">p</span> &lt; 0.01, <sup>bbb</sup> <span class="html-italic">p</span> &lt; 0.001 vs. BTN; <sup>δδδ</sup> <span class="html-italic">p</span> &lt; 0.001: 1W vs. 1M (time effect) according to Kruskal–Wallis ANOVA, and Dunn’s multiple comparison test. Scale bars: 50 µm or 150 µm. Drawings are adapted from the rat brain atlas [<a href="#B23-pathophysiology-31-00047" class="html-bibr">23</a>].</p>
Full article ">Figure 5
<p>Hypothetical percentages of involvement of pathophysiology triggering AD. The <math display="inline"><semantics> <mrow> <mi>Z</mi> </mrow> </semantics></math>-scores, expressed as percentages, were calculated for each experimental group after one week (short-term) or one month (long-term) post-stereotaxic surgery. These <math display="inline"><semantics> <mrow> <mi>Z</mi> </mrow> </semantics></math>-scores serve as indicators for the corresponding pathophysiological hypotheses related to AD. For instance, the <math display="inline"><semantics> <mrow> <mi>Z</mi> </mrow> </semantics></math>-score associated with the beta-amyloid accumulation hypothesis reflects the average of the <math display="inline"><semantics> <mrow> <mi>Z</mi> </mrow> </semantics></math>-scores across all behavioral parameters (Cognition <math display="inline"><semantics> <mrow> <mi>Z</mi> </mrow> </semantics></math>-score), biochemical parameters (Oxidative Stress <math display="inline"><semantics> <mrow> <mi>Z</mi> </mrow> </semantics></math>-score), and histological parameters (Neurodegeneration <math display="inline"><semantics> <mrow> <mi>Z</mi> </mrow> </semantics></math>-score).</p>
Full article ">
12 pages, 723 KiB  
Article
Pregnancy-Associated Plasma Protein A (PAPP-A) as a Predictor of Third Trimester Obesity: Insights from the CRIOBES Project
by Inmaculada Gabaldón-Rodríguez, Carmen de Francisco-Montero, Inmaculada Menéndez-Moreno, Álvaro Balongo-Molina, Ana Isabel Gómez-Lorenzo, Rubén Rodríguez-García, Ángel Vilches-Arenas and Manuel Ortega-Calvo
Pathophysiology 2024, 31(4), 631-642; https://doi.org/10.3390/pathophysiology31040046 - 15 Nov 2024
Viewed by 637
Abstract
Introduction: Our objective in this article was to develop a predictive model for obesity in the third trimester of pregnancy using the plasma and clinical biomarkers that are managed within the Chromosomopathies Programme in the Andalusian Public Healthcare System. Methods: The epidemiological design [...] Read more.
Introduction: Our objective in this article was to develop a predictive model for obesity in the third trimester of pregnancy using the plasma and clinical biomarkers that are managed within the Chromosomopathies Programme in the Andalusian Public Healthcare System. Methods: The epidemiological design was observational, of the unmatched case–control type. The geographical environment was the Seville Primary Healthcare District (DSAP Sevilla). The information was collected between 2011 and 2021. The reference cohort consisted of women who had carried a pregnancy to term. The variables and biomarkers studied correspond to those managed within the primary-care Pregnancy Integrated Care Pathway (ICP). Unconditional binary logistic regression (BLR) models were created, with the outcome variable being whether or not the women were obese in their third trimester of pregnancy. Results: A total of 423 controls and 104 cases of obesity were obtained for women in their third trimester who had not been obese in their first trimester. The average age for the sample group (P50) was 34 years old. The final, most parsimonious model included the variables PAPP-A (p = 0.074), beta-hCG (p = 0.1631), and systolic blood pressure (SBP) (p = 0.085). ROC curve = 0.75 (C.I. at 95%: 0.63–0.86). Discussion: The results of this research can only be extrapolated to primary care and to pregnancies with no complications. PAPP-A has been shown in our research to be a significant predictor of obesity risk in the third trimester of pregnancies with no complications (OR = 0.53; C.I. at 95%: 0.39–0.66; p = 0.04 in the single-variant study; OR = 0.58; C.I. at 95%: 0.29–0.93; p = 0.074 in the multi-variant analysis). This predictive capacity is further enhanced from an operational perspective by beta-hCG and 12-week SBP. Full article
Show Figures

Figure 1

Figure 1
<p>Week of pregnancy when screening was performed (discrete quantitative variable). Measured according to information from DIRAYA or the chromosomal screening. A total of 409 records were taken between the 10th and 11th week of pregnancy (78.8%).</p>
Full article ">Figure 2
<p>Model ROC curve from <a href="#pathophysiology-31-00046-t005" class="html-table">Table 5</a> (most parsimonious).</p>
Full article ">Figure 3
<p>Calibration graph of most parsimonious model shown in <a href="#pathophysiology-31-00046-t005" class="html-table">Table 5</a> (three predictor variables; <span class="html-italic">x</span>-axis predicted probabilities; <span class="html-italic">y</span>-axis observed data).</p>
Full article ">
10 pages, 849 KiB  
Review
IGFBP-2 in Critical Illness: A Prognostic Marker in the Growth Hormone/Insulin-like Growth Factor Axis
by Christos Savvidis, Eleni Kouroglou, Efthymia Kallistrou, Dimitra Ragia, Sofia Dionysopoulou, Georgios Gavriiloglou, Vasiliki Tsiama, Stella Proikaki, Konstantinos Belis and Ioannis Ilias
Pathophysiology 2024, 31(4), 621-630; https://doi.org/10.3390/pathophysiology31040045 - 1 Nov 2024
Viewed by 737
Abstract
Critical illness (CI) triggers complex disruptions in the growth hormone (GH)/insulin-like growth factor (IGF) axis, significantly affecting the dynamics of insulin-like growth-factor-binding proteins (IGFBPs). Among these, IGFBP-2 shows a sustained elevation during CI, which inversely correlates with serum levels of IGF-1, IGFBP-3, and [...] Read more.
Critical illness (CI) triggers complex disruptions in the growth hormone (GH)/insulin-like growth factor (IGF) axis, significantly affecting the dynamics of insulin-like growth-factor-binding proteins (IGFBPs). Among these, IGFBP-2 shows a sustained elevation during CI, which inversely correlates with serum levels of IGF-1, IGFBP-3, and the acid-labile subunit (ALS). Although IGFBP-2 does not directly interact with ALS, it may influence the availability of IGFs by competing with other IGFBPs for binding to IGF-1 and IGF-2. Research suggests that this persistent elevation of IGFBP-2 is largely driven by cytokine activity during CI, reflecting an adaptive response rather than a direct result of GH/IGF axis dysregulation. The clinical importance of IGFBP-2 is emphasized by its correlation with disease severity in conditions like sepsis and coronavirus disease 2019 (COVID-19), where its levels are markedly elevated compared to healthy controls and are similar to those observed in sepsis from various causes. Beyond its role in endocrine regulation, IGFBP-2 appears to play a part in metabolic and inflammatory pathways. Elevated IGFBP-2 levels have been linked to increased mortality and longer hospital stays, indicating its potential utility as a prognostic marker. Furthermore, measuring plasma IGFBP-2 may have other diagnostic applications, aiding in the assessment of CI when traditional biomarkers are inconclusive. Full article
Show Figures

Figure 1

Figure 1
<p>Growth hormone (GH), insulin-like growth factor (IGF-1), and IGF-binding proteins (IGFBP)-1 to -6 in critical illness (CI). In CI, the increased IGFBPs form binary complexes with IGF-1, prolonging the latter’s action, whereas the decreased IGFBPs form ternary complexes with IGF-1 and the acid-labile subunit (ALS); upwards facing arrow: increase, downwards facing arrow: decrease.</p>
Full article ">Figure 2
<p>The role of IGFBP-2 in cytokine regulation of the GH/IGF axis: central influences on cancer, metabolism, and infectious diseases. A. Cytokines and GH Secretion: Cytokines modulate the secretion of growth hormone (GH) from the pituitary gland. During inflammatory responses, there is typically a reduction in the pulsatility and overall secretion of GH (indicated by the red solid line), signifying a suppressive effect. B. Impact on Liver Function: While GH normally stimulates IGF-1 production in the liver, cytokines can impair this process, leading to decreased levels of circulating IGF-1 (red square dotted line), representing a negative regulatory effect. C. GH Receptor and Signaling: Cytokines may decrease the expression and signaling efficiency of GH receptors, reducing tissue sensitivity and efficacy, a phenomenon known as GH resistance (red dash dotted line). D. IGFBPs Regulation: Cytokines alter the levels of insulin-like growth-factor-binding proteins (IGFBPs), like IGFBP-1 and IGFBP-2. These proteins regulate the availability and activity of IGFs by binding and preventing their interaction with receptors (green solid line), showcasing a positive regulatory mechanism. E. IGFBP-2’s Diverse Roles: Cancer: IGFBP-2 promotes cancer progression by enhancing tumor growth and vascular development, partly through stimulating angiogenesis mediated by hypoxia-inducible factors and VEGF. Metabolism: Interacts with leptin to regulate insulin sensitivity and glucose metabolism. Higher IGFBP-2 levels are linked to reduced adipogenesis and better glucose control, potentially protecting against obesity and type 2 diabetes. Critical Illnesses: In conditions like COVID-19, elevated IGFBP-2 levels correlate with increased disease severity, highlighting its potential as a prognostic biomarker (Green lines signify positive regulatory effects that enhance or promote physiological functions. Red lines indicate negative regulatory effects that suppress or diminish physiological functions).</p>
Full article ">
13 pages, 832 KiB  
Article
Factor V Leiden (R506Q), Prothrombin G20210A, and MTHFR C677T Variants and Thrombophilia in Qatar Biobank Participants: A Case Control Study
by Sapha Shibeeb, Nada Al-Rayashi, Nehal Shams, Tameem Hadvan, Ejaife O. Agbani and Atiyeh M. Abdallah
Pathophysiology 2024, 31(4), 608-620; https://doi.org/10.3390/pathophysiology31040044 - 21 Oct 2024
Viewed by 912
Abstract
Background: Thrombophilia, a predisposition to develop blood clots, is very common and can have serious sequelae. Aim: This study aimed to determine the prevalence of three thrombophilia-related genetic variants—factor V Leiden (FVL), prothrombin (F2) G20210A, and MTHFR C677T—in the Qatari population and their [...] Read more.
Background: Thrombophilia, a predisposition to develop blood clots, is very common and can have serious sequelae. Aim: This study aimed to determine the prevalence of three thrombophilia-related genetic variants—factor V Leiden (FVL), prothrombin (F2) G20210A, and MTHFR C677T—in the Qatari population and their associations with self-reported thrombosis. Methods: We analysed samples from 408 Qatari participants [304 controls and 104 with self-reported thrombosis (deep vein thrombosis, pulmonary embolus, or ischaemic stroke)] from the Qatar Biobank. FVL (rs6025), F2 (rs1799963), and MTHFR (rs1801133) variants were genotyped using TaqMan assays. Results: Participants with self-reported thrombosis were older and more likely to be female. FVL A allele carriage (GA + AA vs. GG) was significantly higher in thrombosis cases (OR 3.6, p = 0.0002). In addition, individuals carrying FVL AA and GA genotypes had a lower mean platelet volume on average than those with the GG genotype (p = 0.03). MTHFR C677T did not show a similar association, and the F2 G20210A variant was too rare for analysis. Conclusions: There were significant differences in FVL A allele carriage between individuals with a history of thrombosis and the control group. Future research should explore the complex interplay between genetics and environment in thrombosis risk within this population. Full article
Show Figures

Figure 1

Figure 1
<p>Differences in laboratory parameters between patients with different factor V genotypes. Hb—haemoglobin (g/dL); RCC—red blood cell counts; WCC—white blood cell counts; PLT—platelet counts; MPV—mean platelet volume (fl); MCV—mean corpuscular volume (fl); ChoT—total cholesterol (mmol/L); HDL—high-density lipoprotein cholesterol (mmol/L); UA—uric acid (µmol/L); PT—prothrombin time (seconds); APTT—activated partial thromboplastin time (seconds); Fbg—fibrinogen (g/L); Hcys—homocysteine (µmol/L); CRP—C-reactive protein (mg/L); INR—international normalised ratio. * <span class="html-italic">p</span>-value ≤ 0.05 considered significant. * Significant differences were found between two laboratory test (MPV and HDL) and FV G1691A variants in this cohort of patients.</p>
Full article ">Figure 2
<p>Differences in laboratory parameters among healthy controls with different Factor V genotypes. Hb—haemoglobin (g/dL); RCC—red blood cell counts; WCC—white blood cell counts; PLT—platelet counts; MPV—mean platelet volume (fl); MCV—mean corpuscular volume (fl); ChoT—total cholesterol (mmol/L); HDL—high-density lipoprotein cholesterol (mmol/L); UA—uric acid (µmol/L); PT—prothrombin time (seconds); APTT—activated partial thromboplastin time (seconds); Fbg—fibrinogen (g/L); Hcys—homocysteine (µmol/L); CRP—C-reactive protein (mg/L); INR—international normalised ratio. No significant difference was found between FV G1691A variants and healthy individuals in this cohort.</p>
Full article ">
12 pages, 1012 KiB  
Review
Flavonoid-Mediated Suppression of Tumor Angiogenesis: Roles of Ang-Tie/PI3K/AKT
by Shallu Saini, Hardeep Singh Tuli, Reena V. Saini, Adesh K. Saini, Katrin Sak, Damandeep Kaur, Moyad Shahwan, Ritu Chauhan and Abhishek Chauhan
Pathophysiology 2024, 31(4), 596-607; https://doi.org/10.3390/pathophysiology31040043 - 12 Oct 2024
Viewed by 1107
Abstract
Angiogenesis is a process involved in the formation of new blood capillaries from pre-existing ones. It is regulated by several anti-angiogenic molecules involved in tumor growth and metastasis. The endothelial angiopoietin Ang-Tie/PI3K/AKT growth receptor pathway is necessary for healthy vascular development. The activation [...] Read more.
Angiogenesis is a process involved in the formation of new blood capillaries from pre-existing ones. It is regulated by several anti-angiogenic molecules involved in tumor growth and metastasis. The endothelial angiopoietin Ang-Tie/PI3K/AKT growth receptor pathway is necessary for healthy vascular development. The activation of AKT is controlled by a multistep process involving phosphoinositide 3-kinase (PI3K). This article aims to provide an overview of the role and mechanism of the Ang-Tie/PI3K/AKT signaling pathways and the potential of flavonoids as anti-angiogenic drugs. Flavonoids have shown great potential in preventing angiogenesis by targeting signaling pathways and exhibit additional anti-cancer properties. Research studies have revealed that the currently available anti-angiogenic drugs do not meet the safety and efficacy standards for treating tumor growth. Phytocompounds have long been a valuable resource for the development of novel therapeutic drugs. This article explores recent findings explaining the role and mechanism of the Ang-Tie/PI3K/AKT signaling pathways, as well as the interaction of flavonoids with angiogenic signaling pathways as a novel therapeutic approach. Several investigations have shown that synergistic studies of natural phytocompounds have great potential to target these pathways to inhibit tumor growth. Therefore, flavonoid-based medications may offer a more effective synergistic strategy to treat cancer. Full article
Show Figures

Figure 1

Figure 1
<p>The general structure of Flavonoids and their subclasses [<a href="#B9-pathophysiology-31-00043" class="html-bibr">9</a>].</p>
Full article ">Figure 2
<p>Role of Ang1 in the angiogenesis and cell proliferation pathway.</p>
Full article ">Figure 3
<p>Ang-Tie2 Signaling pathway [<a href="#B53-pathophysiology-31-00043" class="html-bibr">53</a>].</p>
Full article ">
13 pages, 1056 KiB  
Review
Pathophysiology and Prevention of Manual-Ventilation-Induced Lung Injury (MVILI)
by Luke A. White, Steven A. Conrad and Jonathan Steven Alexander
Pathophysiology 2024, 31(4), 583-595; https://doi.org/10.3390/pathophysiology31040042 - 12 Oct 2024
Viewed by 2246
Abstract
Manual ventilation, most commonly with a bag-valve mask, is a form of short-term ventilation used during resuscitative efforts in emergent and out-of-hospital scenarios. However, compared to mechanical ventilation, manual ventilation is an operator-dependent skill that is less well controlled and is highly subject [...] Read more.
Manual ventilation, most commonly with a bag-valve mask, is a form of short-term ventilation used during resuscitative efforts in emergent and out-of-hospital scenarios. However, compared to mechanical ventilation, manual ventilation is an operator-dependent skill that is less well controlled and is highly subject to providing inappropriate ventilation to the patient. This article first reviews recent manual ventilation guidelines set forth by the American Heart Association and European Resuscitation Council for providing appropriate manual ventilation parameters (e.g., tidal volume and respiratory rate) in different patient populations in the setting of cardiopulmonary resuscitation. There is then a brief review of clinical and manikin-based studies that demonstrate healthcare providers routinely hyperventilate patients during manual ventilation, particularly in emergent scenarios. A discussion of the possible mechanisms of injury that can occur during inappropriate manual hyperventilation follows, including adverse hemodynamic alterations and lung injury such as acute barotrauma, gastric regurgitation and aspiration, and the possibility of a subacute, inflammatory-driven lung injury. Together, these injurious processes are described as manual-ventilation-induced lung injury (MVILI). This review concludes with a discussion that highlights recent progress in techniques and technologies for minimizing manual hyperventilation and MVILI, with a particular emphasis on tidal-volume feedback devices. Full article
Show Figures

Figure 1

Figure 1
<p>Mechanisms of MVILI. Manual hyperventilation increases intrathoracic pressure leading to adverse hemodynamic changes, including decreased venous return (VR), cardiac output (CO), and coronary perfusion pressure (CPP). Additionally, increased inspiratory pressures can open the lower esophageal sphincter, causing gastric insufflation, regurgitation, and aspiration. Vigorous manual ventilation may also lead to acute barotrauma (pneumothorax, pneumomediastinum, pneumoperitoneum, and subcutaneous emphysema) and possibly a sub-barotraumatic, inflammation-driven injury lung injury. Graphic design by David Wright.</p>
Full article ">Figure 2
<p>Tidal-volume feedback devices. Authors’ rendering of the TVD based on [<a href="#B67-pathophysiology-31-00042" class="html-bibr">67</a>]. Cropped and edited images of the Amflow<sup>®</sup> [<a href="#B68-pathophysiology-31-00042" class="html-bibr">68</a>], RTVFD (a, tidal volume; b, inspiration time; c, peak pressure) [<a href="#B69-pathophysiology-31-00042" class="html-bibr">69</a>], VFD [<a href="#B70-pathophysiology-31-00042" class="html-bibr">70</a>], and BENGI [<a href="#B71-pathophysiology-31-00042" class="html-bibr">71</a>] reproduced under Creative Commons Attribution Non-Commercial License 4.0.</p>
Full article ">
24 pages, 11796 KiB  
Article
Multiple Benefits of Empagliflozin in PCOS: Evidence from a Preclinical Rat Model
by Dejana Rakic, Vladimir Jakovljevic, Vladimir Zivkovic, Jovana Jakovljevic Uzelac, Nikola Jovic, Maja Muric, Bozidar Pindovic, Aleksandra Dimitrijevic, Petar Arsenijevic, Jovan Rakic, Slobodanka Mitrovic, Tatjana Vulovic and Jovana Joksimovic Jovic
Pathophysiology 2024, 31(4), 559-582; https://doi.org/10.3390/pathophysiology31040041 - 9 Oct 2024
Viewed by 1048
Abstract
Polycystic ovary syndrome (PCOS) is the most common complex endocrinological condition of women that is associated with infertility and metabolic disorders during the reproductive period. Recently, a great deal of research has focused on the etiopathogenesis of this disorder and the modulation of [...] Read more.
Polycystic ovary syndrome (PCOS) is the most common complex endocrinological condition of women that is associated with infertility and metabolic disorders during the reproductive period. Recently, a great deal of research has focused on the etiopathogenesis of this disorder and the modulation of therapeutic approaches. There are still many controversies in the choice of therapy, and metformin is one of the most commonly used agents in the treatment of PCOS. Considering the link between metabolic disorders and PCOS, glycemic status is crucial in these patients, and sodium-glucose cotransporter type 2 inhibitors (SGLT2is) represent a potentially promising new therapeutic approach. These drugs have been shown to improve glucose metabolism, reduce adipose tissue, decrease oxidative stress, and protect the cardiovascular system. These data prompted us to investigate the effects of empagliflozin (EMPA) in a PCOS rat model and compare them with the effects of metformin. We confirmed that EMPA positively affects somatometric parameters, glucose and lipid metabolism, and the levels of sex hormones, as well as reduces oxidative stress and improves ovarian function and morphology. Administration of EMPA at doses of 5 mg/kg, 15 mg/kg, and 45 mg/kg during a 4-week treatment period improved, as induced by estradiol valerate and a high-fat diet, the metabolic and reproductive statuses in a PCOS rat model. The best effects, which were comparable to the effects of metformin, were achieved in groups receiving the middle and highest applied doses of EMPA. These results may prompt further clinical research on the use of EMPA in patients with PCOS. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Bodyweight changes during the duration of the experiment.</p>
Full article ">Figure 2
<p>Body weight changes before (<b>A</b>) and after (<b>B</b>) EMPA and MET treatments. * statistical significance at level <span class="html-italic">p</span> &lt; 0.05 compared to the P group; ** statistical significance at level <span class="html-italic">p</span> &lt; 0.01 compared to the P group.</p>
Full article ">Figure 3
<p>Changes in the estrus cycle in five rats induced with PCOS and after the applied treatments. Y-axis legend: D—diestrus, M—metaestrus, E—estrus, and P—proestrus.</p>
Full article ">Figure 3 Cont.
<p>Changes in the estrus cycle in five rats induced with PCOS and after the applied treatments. Y-axis legend: D—diestrus, M—metaestrus, E—estrus, and P—proestrus.</p>
Full article ">Figure 4
<p>The proportions of different estrus cycle stages in the three groups were analyzed using the Chi-square test, and the differences were evaluated by z-test. * statistically significant difference compared to the P group (<span class="html-italic">p</span> &lt; 0.05), # statistically significant difference compared to the P+E1 group (<span class="html-italic">p</span> &lt; 0.05), and <span>$</span> statistically significant difference compared to the P+E2 group (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 5
<p>The blood pressure parameters in different groups. (<b>A</b>) systolic arterial pressure; (<b>B</b>) diastolic arterial pressure; (<b>C</b>) heart frequency; (<b>D</b>) pulse pressure; and (<b>E</b>) mean arterial pressure. Bars represent the means ± SEM. ** statistical significance at level <span class="html-italic">p</span> &lt; 0.01 compared to the P group; # statistical significance at level <span class="html-italic">p</span> &lt; 0.05 compared to the P+E1 group; and <span>$</span> statistical significance at level <span class="html-italic">p</span> &lt; 0.05 compared to the P+E2 group.</p>
Full article ">Figure 6
<p>Markers of oxidative stress in different groups. (<b>A</b>) levels of O<sub>2</sub><sup>−</sup>; (<b>B</b>) levels of H<sub>2</sub>O<sub>2</sub>; (<b>C</b>) levels of NO<sub>2</sub>; (<b>D</b>) levels of TBARS. Bars represents the means ± SEM. ** statistical significance at level <span class="html-italic">p</span> &lt; 0.01 compared to the P group; ## statistical significance at level <span class="html-italic">p</span> &lt; 0.01 compared to the P+E1 group; and <span>$</span><span>$</span> statistical significance at level <span class="html-italic">p</span> &lt; 0.01 compared to the P+E2 group.</p>
Full article ">Figure 7
<p>The levels of anti-oxidative enzymes in different groups. (<b>A</b>) levels of GSH; (<b>B</b>) levels of CAT; and (<b>C</b>) levels of SOD. Bars represent the means ± SEM. * statistical significance at level <span class="html-italic">p</span> &lt; 0.05 compared to the P group; ** statistical significance at level <span class="html-italic">p</span> &lt; 0.01 compared to the P group; # statistical significance at level <span class="html-italic">p</span> &lt; 0.05 compared to the P+E1 group; ## statistical significance at level <span class="html-italic">p</span> &lt; 0.01 compared to the P+E1 group; and <span>$</span> statistical significance at level <span class="html-italic">p</span> &lt; 0.05 compared to the P+E2 group.</p>
Full article ">Figure 8
<p>The levels of sex hormones in different groups. (<b>A</b>) estradiol levels; (<b>B</b>) progesterone levels; (<b>C</b>) Testosterone levels; (<b>D</b>) FSH levels; and (<b>E</b>) LH levels.Bars represent the means ± SEM. * statistical significance at level <span class="html-italic">p</span> &lt; 0.05 compared to the P group; ** statistical significance at level <span class="html-italic">p</span> &lt; 0.01 compared to the P group; # statistical significance at level <span class="html-italic">p</span> &lt; 0.05 compared to the P+E1 group; and ## statistical significance at level <span class="html-italic">p</span> &lt; 0.01 compared to the P+E1 group.</p>
Full article ">Figure 9
<p>(<b>A</b>) the corpus luteum count; (<b>B</b>) the cystic follicles count. Bars represent the means ± SEM. ** statistical significance at level <span class="html-italic">p</span> &lt; 0.01 compared to the P group; ## statistical significance at level <span class="html-italic">p</span> &lt; 0.01 compared to the P+E1 group.</p>
Full article ">Figure 10
<p>Representative views of the ovaries of the examined groups. (<b>A</b>) the P group; (<b>B</b>) the P+E1 group; (<b>C</b>) the P+E2 group; (<b>D</b>) the P+E3 group; and (<b>E</b>) the P+M group.</p>
Full article ">Figure 11
<p>The surfaces and diameters of the subcutaneous fat tissue. Bars represent the mean values ± SEM. * statistically significant difference compared to the P group <span class="html-italic">p</span> &lt; 0.05; ** statistically significant difference compared to the P group <span class="html-italic">p</span> &lt; 0.01; and # statistically significant difference when comparing the P+E2 and P+E3 groups with the P+E1 group <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 12
<p>The surface area and diameter of the adipocytes of periovarian fat tissue. Bars represent the mean values ± SEM. ** statistically significant difference compared to the P group <span class="html-italic">p</span> &lt; 0.01; and ## statistically significant difference when comparing the P+E3 and P+M groups with the P+E1 group <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Scheme 1
<p>Summary scheme of the effects of EMPA in a PCOS rat model. PCOS—polycystic ovary syndrome; EMPA—empagliflozin; and MET—metformin.</p>
Full article ">
14 pages, 1264 KiB  
Review
Pathways to Alzheimer’s Disease: The Intersecting Roles of Clusterin and Apolipoprotein E in Amyloid-β Regulation and Neuronal Health
by Alexandru Laslo, Laura Laslo, Eliza-Mihaela Arbănași, Alexandru-Andrei Ujlaki-Nagi, Laura Chinezu, Adrian Dumitru Ivănescu, Emil-Marian Arbănași, Roxana Octavia Cărare, Bogdan Andrei Cordoș, Ioana Adriana Popa and Klara Brînzaniuc
Pathophysiology 2024, 31(4), 545-558; https://doi.org/10.3390/pathophysiology31040040 - 2 Oct 2024
Viewed by 1465
Abstract
One of the hallmarks of Alzheimer’s disease (AD) is the deposition of amyloid-β (Aβ) within the extracellular spaces of the brain as plaques and along the blood vessels in the brain, a condition also known as cerebral amyloid angiopathy (CAA). Clusterin (CLU), or [...] Read more.
One of the hallmarks of Alzheimer’s disease (AD) is the deposition of amyloid-β (Aβ) within the extracellular spaces of the brain as plaques and along the blood vessels in the brain, a condition also known as cerebral amyloid angiopathy (CAA). Clusterin (CLU), or apolipoprotein J (APOJ), is a multifunctional glycoprotein that has a role in many physiological and neurological conditions, including AD. The apolipoprotein E (APOE) is a significant genetic factor in AD, and while the primary physiological role of APOE in the brain and peripheral tissues is to regulate lipid transport, it also participates in various other biological processes, having three basic human forms: APOE2, APOE3, and APOE4. Notably, the APOE4 allele substantially increases the risk of developing late-onset AD. The main purpose of this review is to examine the roles of CLU and APOE in AD pathogenesis in order to acquire a better understanding of AD pathogenesis from which to develop targeted therapeutic approaches. Full article
Show Figures

Figure 1

Figure 1
<p>The morphology of APOE isoforms. APOE is a soluble protein, possessing N-terminal and C-terminal domains that are connected by a central hinge region. The N-terminal domain contains the receptor-binding domain (orange), and the C-terminal domain contains the lipid-binding region (red). The isoforms are different from each other at amino acid positions 112 and 158. Position 158 (C158) in APOE2 hosts cysteine, leading to deficient receptor binding; position 112 (R112) in APOE4 hosts arginine. This changes the conformation of the domain as R61 is exposed and interacts with C255 at the C-terminal domain (shown with the red dotted line). This phenomenon of “domain interaction” represents the biophysical basis for differences in the properties and function of APOE4 compared to the other isoforms; for example, the preference for very-low-density lipoproteins over high-density lipoproteins. In APOE2 and APOE3, which possess C112 rather than R112, the R61 is hidden and there is no such interaction at this domain. Image produced with BioRender, recreated from Celia G. Fernandez et al. [<a href="#B72-pathophysiology-31-00040" class="html-bibr">72</a>].</p>
Full article ">Figure 2
<p>The roles of APOE isoforms (APOE2/3/4) in the interactions between astrocytes and neurons. Activation of liver X receptor (LXR) and retinoid X receptor (RXR) regulate the expression of isoforms of APOE in astrocytes. ATP-binding cassette transporter (ABCA1) is responsible for the lipidation of the protein ApoE encoded by APOE and its secretion to the extracellular space. ApoE in the extracellular space binds to several neuronal lipid receptors, including very-low-density lipoprotein receptor (VLDLR), low-density lipoprotein receptor (LDLR), low-density lipoprotein receptor-related protein 1 (LRP1), and heparan sulfate proteoglycans (HSPGs). The lipidation status of APOE isoforms promotes individual receptor affinities. The apoE4 isoform has a low-lipidation status, forms non-lipidated apoE4 aggregates, and has a poor lipid turnover, leading, in turn, to neuronal lipid droplet accumulation. This results in damage to the mitochondria and production of reactive oxygen species (ROS). ApoE4 promotes the formation of endosomes and the degradation of synaptic receptors such as AMPA or NMDA and the consequent impaired synaptic function. Image produced with BioRender, recreated from R. Fernandez-Calle et al. [<a href="#B102-pathophysiology-31-00040" class="html-bibr">102</a>].</p>
Full article ">
15 pages, 3414 KiB  
Article
Early Radiation-Induced Changes in Lung Tissue and Intercellular Junctions: Implications for Tissue Repair and Fibrosis
by Ekaterina S. Karetnikova, Alexandra A. Livanova, Arina A. Fedorova and Alexander G. Markov
Pathophysiology 2024, 31(4), 531-544; https://doi.org/10.3390/pathophysiology31040039 - 24 Sep 2024
Viewed by 770
Abstract
Early changes in lung tissue following ionizing radiation (IR) initiate processes that may lead to either regeneration or fibrosis. Intercellular junction proteins play a crucial role in the organization and function of epithelial tissues, both under normal conditions and after injuries. Alterations in [...] Read more.
Early changes in lung tissue following ionizing radiation (IR) initiate processes that may lead to either regeneration or fibrosis. Intercellular junction proteins play a crucial role in the organization and function of epithelial tissues, both under normal conditions and after injuries. Alterations in the expression and localization of these proteins can influence the fate of epithelial cells. This study aims to investigate the effects of IR on lung tissue structure, as well as on the levels and distribution of intercellular junction proteins. Wistar rats were subjected to total X-ray irradiation at doses of 2 and 10 Gy. Lung tissue samples were collected for Western blot and histological analysis 72 h post-IR. IR at doses of 2 and 10 Gy led to structural changes in lung tissue and elevated levels of E-cadherin. The 10 Gy IR resulted in increased claudin-4 and occludin in lung parenchyma, decreased claudin-8 and claudin-12 in bronchial epithelium and endothelium, and suppression of apoptosis. Data evaluation indicated that alterations in the protein composition of intercellular junctions are essential processes in lung tissue at early stages after IR, and at least some of these alterations are associated with adaptation. Full article
(This article belongs to the Collection Feature Papers in Pathophysiology)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>The effects of ionizing radiation (IR) on body weight in rats. The group of sham-irradiated rats had an increase in mean body weight (<span class="html-italic">n</span> = 8). IR 2 Gy caused arrest of body weight gain in animals (<span class="html-italic">n</span> = 8). The group of rats irradiated at the dose of 10 Gy had a daily decrease in body weight (<span class="html-italic">n</span> = 8). Data are presented as a percentage of the average weight of the groups at the beginning of the tests. Two-way ANOVA followed by Tukey’s multiple comparisons test, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 2
<p>IR at doses of 2 and 10 Gy causes changes in the structure of lung tissue 72 h after exposure. Rat lung tissue stained with H&amp;E (<b>a</b>,<b>b</b>). IR at doses of 2 and 10 Gy causes microdystelectasis (<b>a</b>), foci of alveolar hyperinflation (<b>b</b>), a decrease in the extent of the air–tissue boundary (<b>c</b>), and a decrease in the percentage of lung tissue area occupied by nuclei (<b>d</b>). Nested one-way ANOVA followed by Tukey’s multiple comparisons test, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001; <span class="html-italic">N</span> = 60, <span class="html-italic">n</span> = 4.</p>
Full article ">Figure 3
<p>Bronchioles (<b>a</b>) and vessels (<b>b</b>) in the lung tissue of rats irradiated at doses of 0, 2, and 10 Gy. The 10 Gy IR caused lung vessel congestion (<b>b</b>). Staining with H&amp;E. V—vessel; B—bronchiole.</p>
Full article ">Figure 4
<p>E-cadherin, claudin-1, -3, -4, -5 -8, -12, -18, occludin, and tricellulin in rat lungs 72 h after IR at doses of 0, 2, and 10 Gy. (<b>a</b>) Representative blots. Full images of the Western blot are in the <a href="#app1-pathophysiology-31-00039" class="html-app">Supplementary Material (Figures S2–S12)</a>. (<b>b</b>,<b>c</b>) Western blot analysis of the intercellular junction proteins levels. The intensity of bends was normalized to the intensity of β-actin bends in the corresponding samples. One-way ANOVA followed by Tukey’s multiple comparisons test, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001; <span class="html-italic">n</span> = 7–8.</p>
Full article ">Figure 5
<p>MLCK, cleaved caspase-3, α-SMA, and DDAH1 in rat lungs 72 h after IR at doses of 0, 2, and 10 Gy. (<b>a</b>) Representative blots. Full images of the Western blot are in the <a href="#app1-pathophysiology-31-00039" class="html-app">Supplementary Material (Figures S13–S16)</a>. (<b>b</b>) Western blot analysis of MLCK, cleaved caspase-3, α-SMA, and DDAH1. The intensity of bends was normalized to the intensity of β-actin bends in the corresponding samples. One-way ANOVA followed by Tukey’s multiple comparisons test, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01; <span class="html-italic">n</span> = 7–8.</p>
Full article ">Figure 6
<p>Immunofluorescence staining of lung tissue with antibody to claudin-8 (green) and DAPI (blue). (<b>a</b>) Claudin-8 in tight junctions between endothelial cells in rat lungs after IR at doses of 0, 2, and 10 Gy. (<b>b</b>) IR at doses of 2 and 10 Gy caused the appearance of claudin-8 in bronchial epithelial cells. V—vessel; B—bronchus.</p>
Full article ">Figure 7
<p>Immunofluorescence staining of lung tissue with antibody to claudin-12 (green) and DAPI (blue). Claudin-12 in bronchial epithelium and endothelium of rat lung tissue of the control group (0 Gy) and 2 Gy IR rats. The 10 Gy IR caused the disappearance of claudin-12 from most of the tight junctions. V—vessel; B—bronchus.</p>
Full article ">
Previous Issue
Next Issue
Back to TopTop